Skip to content
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Advanced
  • Reply to Correspondence to “It...
  • Cite this
  • Text this
  • Email this
  • Print
  • Export Record
    • Export to RefWorks
    • Export to EndNoteWeb
    • Export to EndNote
  • Permanent link
Reply to Correspondence to “Itch in patients with cutaneous T-cell lymphoma as a quality of life indicator”

Reply to Correspondence to “Itch in patients with cutaneous T-cell lymphoma as a quality of life indicator”

Bibliographic Details
Main Authors: Rosanne Ottevanger, MD, Sylvia van Beugen, MSc, PhD, Andrea W.M. Evers, MSc, PhD, Rein Willemze, MD, PhD, Maarten H. Vermeer, MD, PhD, Koen D. Quint, MD, PhD
Format: Article
Language:English
Published: Elsevier 2023-03-01
Series:JAAD International
Subjects:
cutaneous T-cell lymphoma
itch
mycosis fungoides
pruritus
quality of life
Sézary syndrome
Online Access:http://www.sciencedirect.com/science/article/pii/S2666328722001535
  • Holdings
  • Description
  • Similar Items
  • Staff View

Internet

http://www.sciencedirect.com/science/article/pii/S2666328722001535

Similar Items

  • Itch in patients with cutaneous T-cell lymphoma as a quality of life indicatorCapsule Summary
    by: Rosanne Ottevanger, MD, et al.
    Published: (2022-12-01)
  • Use of Pegylated Interferon Alpha-2a in Cutaneous T-cell Lymphoma: A Retrospective Case Collection
    by: Janika Gosmann, et al.
    Published: (2023-10-01)
  • Dupilumab Treatment in Two Patients with Cutaneous T-cell Lymphomas
    by: Ingrid Lazaridou, et al.
    Published: (2020-09-01)
  • Neuropathic itch treated with oral cannabinoids: A case series
    by: Catherine Besner Morin, MD, et al.
    Published: (2021-11-01)
  • Pembrolizumab and palliative radiotherapy in 2 cases of refractory mycosis fungoides
    by: Christina J. Walker, MD, et al.
    Published: (2021-01-01)

Search Options

  • Search History
  • Advanced Search

Find More

  • Browse the Catalog
  • Browse Alphabetically
  • Explore Channels
  • Course Reserves
  • New Items

Need Help?

  • Search Tips
  • Ask a Librarian
  • FAQs